Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Therapeutic Advances in Medical Oncology|April 29, 2026
Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2018
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysisHideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, et al.
Cancers|June 2, 2021
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter StudyKaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto, et al.
BMC Cancer|May 27, 2026
Effect of biliary drainage and biliary tract infection in unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: a multicenter, prospective cohort study (NAPOLEON-2)Wataru Yoshioka, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
International Journal of Cancer|August 1, 2025
Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acidTomonori Araki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
Scientific Reports|July 23, 2024
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxelTaro Shibuki, Taiga Otsuka, Mototsugu Shimokawa, et al.
Oncology|October 20, 2024
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 StudiesTomonori Araki, Machiko Kawahira, Mototsugu Shimokawa, et al.
Pageof 4